Concepedia

Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes

Laura Simon‐Szabó, Márton Kokas, Zoltán Greff, Sándor Boros, Péter Bánhegyi, Lilian Zsákai, Csaba Szántai-Kis, Tibor Vántus, József Mandl, Gábor Bánhegyi,

Bioorganic & Medicinal Chemistry Letters · 2015 · 12 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

Hideaki Kaneto, Yoshihisa Nakatani, Takeshi Miyatsuka et al. · Nature Medicine · 2004 · 336 citations

, , +12

Inhibition of Insulin Sensitivity by Free Fatty Acids Requires Activation of Multiple Serine Kinases in 3T3-L1 Adipocytes

Zhan‐Guo Gao, Xiaoying Zhang, Aamir Zuberi et al. · Molecular Endocrinology · 2004 · 331 citations · Full text

, , +17

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

John L. Stebbins, Surya K. De, Thomas Machleidt et al. · Proceedings of the National Academy of Sciences · 2008 · 188 citations · Full text

, , +17

Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: Evidence for PKC activation and oxidative stress-activated signaling pathways

Rafik Ragheb, Gamila M.L. Shanab, Amina M. Medhat et al. · Biochemical and Biophysical Research Communications · 2009 · 115 citations · Full text

, , +16

Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics

Mary E. Law, Patrick Corsino, Satya Narayan et al. · Molecular Pharmacology · 2015 · 99 citations · Full text

, , +13